BIOTRON LIMITED - Announcements

0.00%

0.3¢

Market Cap $3.318M

Healthcare Biotechnology

Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the... Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the research, development, and commercialization of drugs targeting significant viral diseases with unmet medical need. The Company has BIT225 in clinical development for HIV-1 and COVID-19, and additional preclinical programs including Hepatitis B Virus (HBV). In addition, the Company has several early-stage programs designing drugs that target a class of virus protein known as viroporins, which have a key role in the virus life cycle of a range of viruses, such as Coronavirus, Dengue, Ebola, Middle East Respiratory virus, Influenza and Zika viruses. Its proprietary primary bacterial cell-based screening platform enables rapid screening of target viroporin proteins. Its lead compound, BIT225, is in Phase II development for the treatment of HIV-1. The Company also has a portfolio of preclinical antiviral programs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

BIT	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/12	37.67KB	Share
BIT	Biotron to Present Positive 48 Week Data from HCV Trial	PRICE SENSITIVE	16/10/12	55.68KB	Share
BIT	App 4E / Full Year Statutory Accounts	PRICE SENSITIVE	31/08/12	467.75KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/12	78.17KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	20/04/12	49.11KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/12	144.7KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	24/01/12	49.12KB	Share
BIT	ASX price query and response	PRICE SENSITIVE	16/01/12	72.21KB	Share
BIT	Exercise of Options Raises $8.0 Million	PRICE SENSITIVE	06/01/12	93.74KB	Share
BIT	POSITIVE 3 MONTH DATA FOR BIT225 - 87% VIRUS FREE	PRICE SENSITIVE	07/12/11	71.16KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/11	49.09KB	Share
BIT	HEPATITIS C PHASE 2A TRIAL POSITIVE RESULTS	PRICE SENSITIVE	10/10/11	163.28KB	Share
BIT	Trading Halt	PRICE SENSITIVE	07/10/11	52.95KB	Share
BIT	Landmark HIV Trial Underway	PRICE SENSITIVE	29/09/11	23.57KB	Share
BIT	Year End Accounts and Preliminary Final Report	PRICE SENSITIVE	30/08/11	448.31KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/11	49.14KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	19/04/11	49.12KB	Share
BIT	New Issue - Appendix 3B	PRICE SENSITIVE	04/04/11	116.25KB	Share
BIT	Trading Halt	PRICE SENSITIVE	31/03/11	52.38KB	Share
BIT	Stage 1 of Landmark HCV Drug Trial Completed	PRICE SENSITIVE	10/03/11	52.67KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/11	185.6KB	Share
BIT	Biotron Share Purchase Plan	PRICE SENSITIVE	24/02/11	105.07KB	Share
BIT	Response to ASX Query re Appendix 4C	PRICE SENSITIVE	07/02/11	43.53KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/11	49.08KB	Share
BIT	International Study Supports Biotron's HIV Drug Approach	PRICE SENSITIVE	25/11/10	50.56KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/10	49.21KB	Share
BIT	Phase II HCV Trial Commenced	PRICE SENSITIVE	01/10/10	67.7KB	Share
BIT	Preliminary Final Report	PRICE SENSITIVE	31/08/10	966.84KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/10	49.29KB	Share
BIT	Presentation at International AIDS Conference	PRICE SENSITIVE	23/07/10	35.02KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	22/04/10	49.25KB	Share
BIT	Biotron HCV Drug - International Partner to Progress Trial	PRICE SENSITIVE	18/03/10	68.17KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/10	95.53KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/10	49.19KB	Share
BIT	Breakthrough HIV Treatment Progresses	PRICE SENSITIVE	17/12/09	24.82KB	Share
BIT	HCV Drug Success Presented to International Conference	PRICE SENSITIVE	14/12/09	70.8KB	Share
BIT	Option Entitlement Issue and Appendix 3B	PRICE SENSITIVE	10/12/09	473.84KB	Share
BIT	Trading Halt	PRICE SENSITIVE	09/12/09	59.44KB	Share
BIT	Response to ASX Query re Appendix 4C	PRICE SENSITIVE	17/11/09	67.24KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/09	49.01KB	Share
BIT	Successful HCV Trial Results	PRICE SENSITIVE	06/10/09	34.43KB	Share
BIT	Preliminary Final Report	PRICE SENSITIVE	28/08/09	305.11KB	Share
BIT	Completion of Clinical Stage of HCV Trial	PRICE SENSITIVE	04/08/09	79.29KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	24/07/09	49.11KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/09	56.03KB	Share
BIT	New Issue Annoucement and HCV Trial Update	PRICE SENSITIVE	14/04/09	75.24KB	Share
BIT	Trading Halt	PRICE SENSITIVE	09/04/09	57.35KB	Share
BIT	Biotron Share Purchase Plan	PRICE SENSITIVE	24/02/09	27.25KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	12/02/09	167.15KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	56.04KB	Share

BITAppendix 4C - quarterly
22/10/12	PRICE SENSITIVE	37.67KB	Share
BITBiotron to Present Positive 48 Week Data from HCV Trial
16/10/12	PRICE SENSITIVE	55.68KB	Share
BITApp 4E / Full Year Statutory Accounts
31/08/12	PRICE SENSITIVE	467.75KB	Share
BITAppendix 4C - quarterly
27/07/12	PRICE SENSITIVE	78.17KB	Share
BITAppendix 4C - quarterly
20/04/12	PRICE SENSITIVE	49.11KB	Share
BITHalf Yearly Report and Accounts
28/02/12	PRICE SENSITIVE	144.7KB	Share
BITAppendix 4C - quarterly
24/01/12	PRICE SENSITIVE	49.12KB	Share
BITASX price query and response
16/01/12	PRICE SENSITIVE	72.21KB	Share
BITExercise of Options Raises $8.0 Million
06/01/12	PRICE SENSITIVE	93.74KB	Share
BITPOSITIVE 3 MONTH DATA FOR BIT225 - 87% VIRUS FREE
07/12/11	PRICE SENSITIVE	71.16KB	Share
BITAppendix 4C - quarterly
27/10/11	PRICE SENSITIVE	49.09KB	Share
BITHEPATITIS C PHASE 2A TRIAL POSITIVE RESULTS
10/10/11	PRICE SENSITIVE	163.28KB	Share
BITTrading Halt
07/10/11	PRICE SENSITIVE	52.95KB	Share
BITLandmark HIV Trial Underway
29/09/11	PRICE SENSITIVE	23.57KB	Share
BITYear End Accounts and Preliminary Final Report
30/08/11	PRICE SENSITIVE	448.31KB	Share
BITAppendix 4C - quarterly
27/07/11	PRICE SENSITIVE	49.14KB	Share
BITAppendix 4C - quarterly
19/04/11	PRICE SENSITIVE	49.12KB	Share
BITNew Issue - Appendix 3B
04/04/11	PRICE SENSITIVE	116.25KB	Share
BITTrading Halt
31/03/11	PRICE SENSITIVE	52.38KB	Share
BITStage 1 of Landmark HCV Drug Trial Completed
10/03/11	PRICE SENSITIVE	52.67KB	Share
BITHalf Yearly Report and Accounts
28/02/11	PRICE SENSITIVE	185.6KB	Share
BITBiotron Share Purchase Plan
24/02/11	PRICE SENSITIVE	105.07KB	Share
BITResponse to ASX Query re Appendix 4C
07/02/11	PRICE SENSITIVE	43.53KB	Share
BITAppendix 4C - quarterly
27/01/11	PRICE SENSITIVE	49.08KB	Share
BITInternational Study Supports Biotron's HIV Drug Approach
25/11/10	PRICE SENSITIVE	50.56KB	Share
BITAppendix 4C - quarterly
27/10/10	PRICE SENSITIVE	49.21KB	Share
BITPhase II HCV Trial Commenced
01/10/10	PRICE SENSITIVE	67.7KB	Share
BITPreliminary Final Report
31/08/10	PRICE SENSITIVE	966.84KB	Share
BITAppendix 4C - quarterly
30/07/10	PRICE SENSITIVE	49.29KB	Share
BITPresentation at International AIDS Conference
23/07/10	PRICE SENSITIVE	35.02KB	Share
BITAppendix 4C - quarterly
22/04/10	PRICE SENSITIVE	49.25KB	Share
BITBiotron HCV Drug - International Partner to Progress Trial
18/03/10	PRICE SENSITIVE	68.17KB	Share
BITHalf Yearly Report and Accounts
26/02/10	PRICE SENSITIVE	95.53KB	Share
BITAppendix 4C - quarterly
27/01/10	PRICE SENSITIVE	49.19KB	Share
BITBreakthrough HIV Treatment Progresses
17/12/09	PRICE SENSITIVE	24.82KB	Share
BITHCV Drug Success Presented to International Conference
14/12/09	PRICE SENSITIVE	70.8KB	Share
BITOption Entitlement Issue and Appendix 3B
10/12/09	PRICE SENSITIVE	473.84KB	Share
BITTrading Halt
09/12/09	PRICE SENSITIVE	59.44KB	Share
BITResponse to ASX Query re Appendix 4C
17/11/09	PRICE SENSITIVE	67.24KB	Share
BITAppendix 4C - quarterly
27/10/09	PRICE SENSITIVE	49.01KB	Share
BITSuccessful HCV Trial Results
06/10/09	PRICE SENSITIVE	34.43KB	Share
BITPreliminary Final Report
28/08/09	PRICE SENSITIVE	305.11KB	Share
BITCompletion of Clinical Stage of HCV Trial
04/08/09	PRICE SENSITIVE	79.29KB	Share
BITAppendix 4C - quarterly
24/07/09	PRICE SENSITIVE	49.11KB	Share
BITAppendix 4C - quarterly
29/04/09	PRICE SENSITIVE	56.03KB	Share
BITNew Issue Annoucement and HCV Trial Update
14/04/09	PRICE SENSITIVE	75.24KB	Share
BITTrading Halt
09/04/09	PRICE SENSITIVE	57.35KB	Share
BITBiotron Share Purchase Plan
24/02/09	PRICE SENSITIVE	27.25KB	Share
BITHalf Yearly Report and Accounts
12/02/09	PRICE SENSITIVE	167.15KB	Share
BITAppendix 4C - quarterly
30/01/09	PRICE SENSITIVE	56.04KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $3.318M

Open	High	Low	Value	Volume
0.3¢	0.3¢	0.3¢	$2.225K	890K

Buyers (Bids)

No.	Vol.	Price($)
56	49266483	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	15381642	24

View Market Depth

No.	Vol.	Price($)
56	49266483	0.002
30	73392000	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	15381642	24
0.004	12320414	15
0.005	6690600	5
0.006	1200000	2
0.007	574234	2

Last trade - 15.48pm 12/08/2025 (20 minute delay)

BIT (ASX) Chart

BIOTRON LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available